The Sequenom case has finally been decided by the federal appeals court. The court struck down the patent for a Down Syndrome Test.
We first reported on the case back in January of 2013.
Our most recent update was in June of 2014.
You can read a detailed analysis of the decision on the PharmaPatents blog here.
We predict that the case will be appealed to the US Supreme Court and the SCOTUS will deny cert.
No comments:
Post a Comment